289 related articles for article (PubMed ID: 36306733)
1. Structural basis for Cas9 off-target activity.
Pacesa M; Lin CH; Cléry A; Saha A; Arantes PR; Bargsten K; Irby MJ; Allain FH; Palermo G; Cameron P; Donohoue PD; Jinek M
Cell; 2022 Oct; 185(22):4067-4081.e21. PubMed ID: 36306733
[TBL] [Abstract][Full Text] [Related]
2. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs.
Coelho MA; De Braekeleer E; Firth M; Bista M; Lukasiak S; Cuomo ME; Taylor BJM
Nat Commun; 2020 Aug; 11(1):4132. PubMed ID: 32807781
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of duplex DNA destabilization by RNA-guided Cas9 nuclease during target interrogation.
Mekler V; Minakhin L; Severinov K
Proc Natl Acad Sci U S A; 2017 May; 114(21):5443-5448. PubMed ID: 28484024
[TBL] [Abstract][Full Text] [Related]
4. CRISPR-Cas9 bends and twists DNA to read its sequence.
Cofsky JC; Soczek KM; Knott GJ; Nogales E; Doudna JA
Nat Struct Mol Biol; 2022 Apr; 29(4):395-402. PubMed ID: 35422516
[TBL] [Abstract][Full Text] [Related]
5. Prediction and Validation of Native and Engineered Cas9 Guide Sequences.
Briner AE; Henriksen ED; Barrangou R
Cold Spring Harb Protoc; 2016 Jul; 2016(7):. PubMed ID: 27371591
[TBL] [Abstract][Full Text] [Related]
6. Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling.
Ivanov IE; Wright AV; Cofsky JC; Aris KDP; Doudna JA; Bryant Z
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5853-5860. PubMed ID: 32123105
[TBL] [Abstract][Full Text] [Related]
7. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
Karvelis T; Gasiunas G; Siksnys V
Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
[TBL] [Abstract][Full Text] [Related]
8. Conformational control of Cas9 by CRISPR hybrid RNA-DNA guides mitigates off-target activity in T cells.
Donohoue PD; Pacesa M; Lau E; Vidal B; Irby MJ; Nyer DB; Rotstein T; Banh L; Toh MS; Gibson J; Kohrs B; Baek K; Owen ALG; Slorach EM; van Overbeek M; Fuller CK; May AP; Jinek M; Cameron P
Mol Cell; 2021 Sep; 81(17):3637-3649.e5. PubMed ID: 34478654
[TBL] [Abstract][Full Text] [Related]
9. The length of guide RNA and target DNA heteroduplex effects on CRISPR/Cas9 mediated genome editing efficiency in porcine cells.
Lv J; Wu S; Wei R; Li Y; Jin J; Mu Y; Zhang Y; Kong Q; Weng X; Liu Z
J Vet Sci; 2019 May; 20(3):e23. PubMed ID: 31161741
[TBL] [Abstract][Full Text] [Related]
10. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
11. CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences.
Lin Y; Cradick TJ; Brown MT; Deshmukh H; Ranjan P; Sarode N; Wile BM; Vertino PM; Stewart FJ; Bao G
Nucleic Acids Res; 2014 Jun; 42(11):7473-85. PubMed ID: 24838573
[TBL] [Abstract][Full Text] [Related]
12. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
Zheng W
Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
[TBL] [Abstract][Full Text] [Related]
13. R-loop formation and conformational activation mechanisms of Cas9.
Pacesa M; Loeff L; Querques I; Muckenfuss LM; Sawicka M; Jinek M
Nature; 2022 Sep; 609(7925):191-196. PubMed ID: 36002571
[TBL] [Abstract][Full Text] [Related]
14. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.
Fu Y; Sander JD; Reyon D; Cascio VM; Joung JK
Nat Biotechnol; 2014 Mar; 32(3):279-284. PubMed ID: 24463574
[TBL] [Abstract][Full Text] [Related]
15. Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9.
Singh D; Sternberg SH; Fei J; Doudna JA; Ha T
Nat Commun; 2016 Sep; 7():12778. PubMed ID: 27624851
[TBL] [Abstract][Full Text] [Related]
16. Conformational control of DNA target cleavage by CRISPR-Cas9.
Sternberg SH; LaFrance B; Kaplan M; Doudna JA
Nature; 2015 Nov; 527(7576):110-3. PubMed ID: 26524520
[TBL] [Abstract][Full Text] [Related]
17. The Impact of DNA Topology and Guide Length on Target Selection by a Cytosine-Specific Cas9.
Tsui TKM; Hand TH; Duboy EC; Li H
ACS Synth Biol; 2017 Jun; 6(6):1103-1113. PubMed ID: 28277645
[TBL] [Abstract][Full Text] [Related]
18. CRISPR-Cas9 cleavage efficiency correlates strongly with target-sgRNA folding stability: from physical mechanism to off-target assessment.
Xu X; Duan D; Chen SJ
Sci Rep; 2017 Mar; 7(1):143. PubMed ID: 28273945
[TBL] [Abstract][Full Text] [Related]
19. Frankenstein Cas9: engineering improved gene editing systems.
Vos PD; Filipovska A; Rackham O
Biochem Soc Trans; 2022 Oct; 50(5):1505-1516. PubMed ID: 36305591
[TBL] [Abstract][Full Text] [Related]
20. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
